Lv1
78 积分 2023-09-02 加入
Mosunetuzumab and Polatuzumab Vedotin as First-line Treatment for Large B Cell Lymphoma in Older Unfit or Frail Patients
1天前
求助中
Exposure-response evaluations of venetoclax efficacy and safety in patients with non-Hodgkin lymphoma
2天前
已完结
Cathepsin S regulates germinal center reactions and anti-tumor humoral responses
2天前
已关闭
Efficacy and safety of brexucabtagene autoleucel CAR T-cell therapy with BTK inhibitors in the treatment of relapsed mantle cell lymphoma with central nervous system involvement
5天前
已完结
Using the Iron Chelator Deferasirox to Overcome Venetoclax Resistance in Mantle Cell Lymphoma
5天前
已完结
Phase I study of bendamustine, rituximab, ibrutinib, and venetoclax in relapsed, refractory mantle cell lymphoma
5天前
已完结
Pericardial Effusion and Bruton Tyrosine Kinase Inhibitors in B-Cell Malignant Disease
5天前
已完结
First-in-Human Study of the Reversible BTK Inhibitor Nemtabrutinib in Patients with Relapsed/Refractory Chronic Lymphocytic Leukemia and B-Cell Non–Hodgkin Lymphoma
5天前
已完结
Pericardial Effusion and Bruton Tyrosine Kinase Inhibitors in B-Cell Malignant Disease
5天前
已关闭
Characteristics, treatment, and outcomes of mantle cell lymphoma with cutaneous involvement: a decade-long study at MD Anderson cancer center
5天前
已完结
Epidermal Growth Factor Receptor Pathway Is a Potential Biological Mechanism in Inflammatory Bowel Disease-Induced Psoriasis
皖公网安备34019202002308
